European monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs) - the need to improve quality and comparability

L. WIESSING ; B. GUARITA ; I. GIRAUDON ; BRUMMER-KORVENKONTIO H. ; M. SALMINEN ; COWAN S. A. | 2008
Dans Eurosurveillance (Vol.13, n°21, 22 May 2008) Article : Périodique

ENGLISH : The human immunodeficiency virus (HIV) epidemic among injecting drug users (IDUs) shows different developments in different parts of the European region. In the countries of the European Union (EU) and the European Free Trade Associa[...]

Plus d'info

Ajouter à la sélection

Lien externe

Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening

S. J. M. HAHNE ; I. K. VELDHUIJZEN ; L. WIESSING ; T. A. LIM ; M. SALMINEN ; M. J. VAN DE LAAR | 2013
Dans BMC Infectious Diseases (Vol.13, n°181, 18 April 2013) Article : Périodique

BACKGROUND: Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is improving but not benefiting individuals unaware to be infected. To inform screening policies we assessed (1) the hepatitis B surface antigen (HBs[...]

Plus d'info

Ajouter à la sélection

Lien externe

Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness

G. J. MACARTHUR ; E. VAN VELZEN ; N. E. PALMATEER ; J. KIMBER ; A. PHARRIS ; V. HOPE ; A. TAYLOR ; K. ROY ; E. ASPINALL ; D. GOLDBERG ; T. RHODES ; D. HEDRICH ; M. SALMINEN ; M. HICKMAN ; S. J. HUTCHINSON | 2014
Dans International Journal of Drug Policy (Vol.25, n°1, January 2014) Article : Périodique

BACKGROUND: Injecting drug use is a major risk factor for the acquisition and transmission of HIV and Hepatitis C virus (HCV). Prevention of these infections among people who inject drugs (PWID) is critical to reduce ongoing transmission, morbid[...]

Plus d'info

Ajouter à la sélection